Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.

Saved in:
Bibliographic Details
Title: Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.
Authors: Burkhardt, Jan-Karl1, Shin, Benjamin J.1, Schlaff, Cody D.1, Riina, Howard1, Boockvar, John A.1 jab2029@nyp.org
Source: Journal of Experimental Therapeutics & Oncology. 2011, Vol. 9 Issue 3, p183-186. 4p. 1 Chart, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:13594117